Multiple sclerosis in the Levant: A regional consensus statement
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Informa Healthcare
Abstract
The epidemiology of multiple sclerosis (MS) is rapidly changing in many parts of the world. In a geographic area that was previously associated with low prevalence, recent studies showing high prevalence and fast rising incidence of MS in the Levant countries led us neurologists of this region to meet in a consensus panel, in order to share our latest findings in terms of MS epidemiology and consent on MS management in the Levant. Twelve neurologists and MS experts representing various countries of the Levant (Lebanon, Syria, Jordan and Iraq) have met in Beirut on the 17th of February 2013, shared their latest epidemiological findings, discussed recent MS aspects in the region, and drafted a consensus on MS management relevant to this geographic area. © 2014 Informa Healthcare USA, Inc.
Description
Keywords
Consensus, Epidemiology, Levant, Multiple sclerosis, Disease progression, Humans, Incidence, Middle east, Multiple sclerosis, chronic progressive, Prevalence, Beta1a interferon, Fingolimod, Glatiramer, Interferon beta serine, Mitoxantrone, Natalizumab, Article, Demyelinating disease, Human, Iraq, Jordan, Lebanon, Neurologist, Patient care, Recurrence risk, Syrian arab republic, Treatment response